title: Dilution, storage, and electromyographic guidance in the use of botulinum toxins.
abstract: Botulinim toxin A (BTX-A) is available commercially in two formulations: Botox (Allergan, Inc. Irvine, California) and Dysport (Ipsen Limited, Berkshire, United Kingdom). To use BTX-A successfully for cosmetic purposes, it is important to understand the basic principles of BTX-A therapy and the specific guidelines for its use, including dilution and storage. Injection using electromyographic guidance is helpful in achieving correct placement of BTX-A by locating the muscle responsible for a particular facial line.
authors.affiliation: University of California at Los Angeles, USA. dralan@pacbell.net
authors.forename: Alan M
authors.initials: AM
authors.lastname: Mantell
mesh_terms: D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000627:therapeutic use*; D004356:Drug Storage; D004576:Electromyography; D005152:Facial Muscles / Q000187:drug effects*; D006801:Humans; D007273:Injections, Intramuscular; D009465:Neuromuscular Agents / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A